Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegradable microspheres

被引:57
作者
Yang, TH
Dong, AC
Meyer, J
Johnson, OL
Cleland, JL
Carpenter, JF
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Denver, CO 80262 USA
[2] Univ No Colorado, Dept Chem & Biochem, Greeley, CO 80639 USA
[3] Alkermes, Formulat Dept, Cambridge, MA 02139 USA
[4] Genentech Inc, Pharmaceut Res & Dev, S San Francisco, CA 94080 USA
基金
美国国家科学基金会;
关键词
D O I
10.1021/js980423n
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The purpose of this study was to test the utility of infrared (IR) spectroscopy to determine protein secondary structure in biodegradable microspheres. Encapsulation of proteins within biodegradable polymers, [e.g, poly(lactic-co-glycolic acid) (PLGA)] for controlled drug release has recently been the subject of intense research effort. The ability to assess protein integrity after microsphere production is necessary to successfully produce microspheres that release native proteins. We used IR spectroscopy, a noninvasive method-as opposed to conventional organic solvent extraction or in vitro release at elevated temperature-to assess the secondary structure of recombinant human growth hormone (rhGH) within dry and rehydrated microspheres. PLGA microspheres containing rhGH with different excipients were prepared by a conventional double-emulsion method. The protein IR spectra indicated that the encapsulation process could perturb the structure of rhGH and that excipients could inhibit this damage to varying degrees. A strong positive correlation was found between intensity of the dominant a-helical band in the spectra of rhGH in rehydrated microspheres and the percent monomer released from microspheres during incubation in buffer. We also studied microspheres prepared with zinc-precipitated rhGH. The addition of Zn2+ during microsphere processing partially inhibited protein unfolding and fostered complete refolding of rhGH upon rehydration. In conclusion, IR spectroscopy can serve as a valuable tool to assess protein structure within both dried and rehydrated microspheres.
引用
收藏
页码:161 / 165
页数:5
相关论文
共 11 条
[1]   Counteracting effects of thiocyanate and sucrose on chymotrypsinogen secondary structure and aggregation during freezing, drying, and rehydration [J].
Allison, SD ;
Dong, AC ;
Carpenter, JF .
BIOPHYSICAL JOURNAL, 1996, 71 (04) :2022-2032
[2]  
Carpenter J.F., 1996, Bietechnology and biopharmaceutical manufacturing, processing, and preservation, V1996, P199
[3]   The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres [J].
Cleland, JL ;
Mac, A ;
Boyd, B ;
Yang, J ;
Duenas, ET ;
Yeung, D ;
Brooks, D ;
Hsu, C ;
Chu, H ;
Mukku, V ;
Jones, AJS .
PHARMACEUTICAL RESEARCH, 1997, 14 (04) :420-425
[4]   Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres [J].
Cleland, JL ;
Jones, AJS .
PHARMACEUTICAL RESEARCH, 1996, 13 (10) :1464-1475
[5]  
DONG AC, 1994, METHOD ENZYMOL, V232, P139
[6]   INFRARED SPECTROSCOPIC STUDIES OF LYOPHILIZATION-INDUCED AND TEMPERATURE-INDUCED PROTEIN AGGREGATION [J].
DONG, AC ;
PRESTRELSKI, SJ ;
ALLISON, SD ;
CARPENTER, JF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (04) :415-424
[7]   A month-long effect from a single injection of microencapsulated human growth hormone [J].
Johnson, OL ;
Cleland, JL ;
Lee, HJ ;
Charnis, M ;
Duenas, E ;
Jaworowicz, W ;
Shepard, D ;
Shahzamani, A ;
Jones, AJS ;
Putney, SD .
NATURE MEDICINE, 1996, 2 (07) :795-799
[8]   Quantitation of the area of overlap between second-derivative amide I infrared spectra to determine the structural similarity of a protein in different states [J].
Kendrick, BS ;
Dong, AC ;
Allison, SD ;
Manning, MC ;
Carpenter, JF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (02) :155-158
[9]   DEHYDRATION-INDUCED CONFORMATIONAL TRANSITIONS IN PROTEINS AND THEIR INHIBITION BY STABILIZERS [J].
PRESTRELSKI, SJ ;
TEDESCHI, N ;
ARAKAWA, T ;
CARPENTER, JF .
BIOPHYSICAL JOURNAL, 1993, 65 (02) :661-671
[10]   Improving protein therapeutics with sustained-release formulations [J].
Putney, SD ;
Burke, PA .
NATURE BIOTECHNOLOGY, 1998, 16 (02) :153-157